Procainamide hydrochloride

CAS No. 614-39-1

Procainamide hydrochloride ( Procainamide Hydrochloride; Procainamide Hcl; Pronestyl; Procanbid; Procapan; Procaine Amide )

Catalog No. M15317 CAS No. 614-39-1

Procainamide hydrochloride is a class Ia antiarrhythmic drug that is structurally-related to procaine.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 37 In Stock
100MG 53 In Stock
200MG 77 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Procainamide hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Procainamide hydrochloride is a class Ia antiarrhythmic drug that is structurally-related to procaine.
  • Description
    Procainamide hydrochloride is a class Ia antiarrhythmic drug that is structurally-related to procaine.
  • Synonyms
    Procainamide Hydrochloride; Procainamide Hcl; Pronestyl; Procanbid; Procapan; Procaine Amide
  • Pathway
    Endocrinology/Hormones
  • Target
    AChR
  • Recptor
    AChR; DNA (cytosine-5)-methyltransferase 1; Sodium Channel
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    614-39-1
  • Formula Weight
    271.79
  • Molecular Formula
    C13H21N3O·HCl
  • Purity
    >98%(HPLC)
  • Solubility
    Ethanol: 54 mg/mL warmed (198.68 mM); Water: 54 mg/mL (198.68 mM); DMSO: 54 mg/mL (198.68 mM)
  • SMILES
    CCN(CC)CCNC(=O)C1=CC=C(C=C1)N.Cl
  • Chemical Name
    4-amino-N-[2-(diethylamino)ethyl]benzamide;hydrochloride

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Wojnarowska Z, et al. J Chem Phys. 2012 Apr 28;136(16):164507.
molnova catalog
related products
  • GSK137647A

    GSK137647A is a selective FFA4 agonist.

  • CGS 15943

    CGS 15943 is an orally bioavailable non-xanthine antagonist of Adenosine Receptor.

  • TA-03

    TA-03 is a potent inhibitor of AChE in treatment of cognitive manifestation of AD.